Big-chain pharmacies pushing into primary care, home health


The following is an excerpt from Becker’s Hospital Review.

Retail giants like CVS, Amazon and Walgreens are knocking down the door of the healthcare and primary care space with multibillion-dollar acquisitions adding healthcare organizations to their offerings.

Walgreens is the latest company to make waves through its acquisitions.

Primary care disruptor VillageMD, which is majority-owned by Walgreens, acquired physician practice group Summit Health for $8.9 billion. 

In a recent earnings call, Walgreens CEO Roz Brewer outlined her strategy, saying the company plans to move “swiftly to implement our vision of consumer-centric tech-enabled healthcare solutions that improve outcomes and lower costs for patients, providers and payers.”

Walgreens is just the latest company to take a crack at disrupting primary care.

Amazon made waves with its plans to acquire primary care company One Medical for $3.9 billion.

Despite a challenging economic environment, the company is betting on reinventing primary care in the same way that they changed retail and online shopping. 

However, the economic situation could pose problems for Amazon’s expansion into healthcare. The company recently cited macroeconomic headwinds for its corporate hiring freeze. 

The Covid-19 pandemic made Telehealth and digital health necessary. While Telehealth use is now declining from its peak during the Covid-19 pandemic, it remains more widely used than it was before the Covid-19 pandemic. 

CVS is also focused on acquisitions that improve the convenience of care. The pharmacy company beat out Amazon to acquire home-health company Signify for $8 billion in a deal expected to close in the first half of 2023. 

CVS hopes that its reputation as a retail health company will help it compete with Amazon.

Read more here.


Leave a Comment

Your email address will not be published. Required fields are marked *

1 thought on “Big-chain pharmacies pushing into primary care, home health”

  1. Sharyl this Article ? They would need to be Regulated to make sure there not going to start ripping off people and others in a economic retaliatory measures for getting fined for having to pay for opioid settlements in states ?? I also agree with Sharyl past 2 year findings in various bad drug side effects, in that no new drug should be fast tracked unless there is a extenme need to save lives, out ways a few isolated small bad reactions for greater good of saving lives ..

Scroll to Top